Adams Respiratory Therapeutics, Inc.
Respiratory disorders-focused company prices secondary offering
Published in Healthcare Mergers, Acquisitions and Ventures Week, January 14th, 2006
The company expects the sale of these shares by the selling stockholders to the underwriters to be completed on December 14, 2005, subject to customary closing conditions. The company will not receive any proceeds from the offering.
In addition, the selling stockholders have granted the underwriters an option to purchase up to an additional 849,112 shares to cover over-allotments, if any. The company will not receive any proceeds from the transaction.
Merrill Lynch & Co. and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Accelr8 Technology Corp.
Medical instrumentation maker reports loss of $0.08 per share - American Oriental Bioengineering, Inc.
Chinese pharmaceutical firm reports options to trade on Chicago Board Options Exchange - Amgen
Biotech company to acquire Abgenix for $22.50 per share - AnorMED, Inc.
Hematology-focused biotech company obtains receipts for short-form prospectus - AnorMED, Inc.
Hematology-focused company closes offering for proceeds of $34,500,000 - Antigenics, Inc.
Bruce A. Leicher joins company developing patient-specific immunotherapies as general counsel - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
